UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Common Stock Held in Treasury	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020			88,554,962
Beginning balance at Dec. 31, 2020	$ 583,184		$ 1	$ 770,714	$ (897)	$ (187,691)		$ 1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			271,946
Common stock issued for exercise of employee-based stock options	2,427			2,427
Stock-based compensation	911			911
Net income (loss)	628					628
Unrealized gain (loss) on hedged transactions, net of tax	(134)							(134)
Foreign currency translation adjustment, net of tax	372							372
Ending Balance (in shares) at Mar. 31, 2021			88,826,908
Ending Balance at Mar. 31, 2021	587,388		$ 1	774,052	(897)	(187,063)		1,295
Beginning balance (in shares) at Dec. 31, 2020			88,554,962
Beginning balance at Dec. 31, 2020	583,184		$ 1	770,714	(897)	(187,691)		1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(21,231)
Unrealized gain (loss) on hedged transactions, net of tax	(323)
Foreign currency translation adjustment, net of tax	(971)
Ending Balance (in shares) at Sep. 30, 2021			95,787,780
Ending Balance at Sep. 30, 2021	701,245		$ 68	911,233	(897)	(208,922)		(237)
Beginning balance (in shares) at Dec. 31, 2020			88,554,962
Beginning balance at Dec. 31, 2020	583,184		$ 1	770,714	(897)	(187,691)		1,057
Ending Balance (in shares) at Dec. 31, 2021			95,746,975
Ending Balance at Dec. 31, 2021	$ 709,624	$ (198)	$ 68	916,578	(897)	(206,218)	$ (198)	93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13
Beginning balance (in shares) at Mar. 31, 2021			88,826,908
Beginning balance at Mar. 31, 2021	$ 587,388		$ 1	774,052	(897)	(187,063)		1,295
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	765			765
Net income (loss)	3,397					3,397
Unrealized gain (loss) on hedged transactions, net of tax	(188)							(188)
Foreign currency translation adjustment, net of tax	222							222
Ending Balance (in shares) at Jun. 30, 2021			88,826,908
Ending Balance at Jun. 30, 2021	591,584		$ 1	774,817	(897)	(183,666)		1,329
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			6,093
Common stock issued for exercise of employee-based stock options	56			56
Issuance of common stock in connection with IPO, net of offering costs, underwriting discounts and commissions (in shares)			4,760,000
Issuance of common stock in connection with IPO, net of offering costs, underwriting discounts and commissions	94,523		$ 48	94,475
Issuance of common stock in connection with forgiveness of promissory notes (in shares)			370,182
Issuance of common stock in connection with forgiveness of promissory notes	8,409			8,409
Capital contribution from Stockholder	15,576			15,576
Issuance of restricted shares, net of forfeitures and vesting (in shares)			1,824,597
Issuance of restricted shares, net of forfeitures and vestings			$ 19	(19)
Stock-based compensation	17,919			17,919
Net income (loss)	(25,256)					(25,256)
Unrealized gain (loss) on hedged transactions, net of tax	(1)							(1)
Foreign currency translation adjustment, net of tax	(1,565)							(1,565)
Ending Balance (in shares) at Sep. 30, 2021			95,787,780
Ending Balance at Sep. 30, 2021	701,245		$ 68	911,233	(897)	(208,922)		(237)
Beginning balance (in shares) at Dec. 31, 2021			95,746,975
Beginning balance at Dec. 31, 2021	709,624	(198)	$ 68	916,578	(897)	(206,218)	(198)	93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,112
Common stock issued for exercise of employee-based stock options (in shares)			8,486
Common stock issued for exercise of employee-based stock options	80			80
Issuance of restricted shares, net of forfeitures and vesting (in shares)			533,095
Issuance of restricted shares, net of forfeitures and vestings			$ 5	(5)
Stock-based compensation	5,108			5,108
Net income (loss)	6,236					6,236
Foreign currency translation adjustment, net of tax				(8)				283
Foreign currency translation adjustment, net of tax	275
Ending Balance (in shares) at Mar. 31, 2022			96,289,668
Ending Balance at Mar. 31, 2022	721,125		$ 73	921,753	(897)	(200,180)		376
Beginning balance (in shares) at Dec. 31, 2021			95,746,975
Beginning balance at Dec. 31, 2021	709,624	$ (198)	$ 68	916,578	(897)	(206,218)	$ (198)	93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	27,110
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(7,990)
Ending Balance (in shares) at Sep. 30, 2022			96,548,066
Ending Balance at Sep. 30, 2022	748,214		$ 75	936,239	(897)	(179,306)		(7,897)
Beginning balance (in shares) at Mar. 31, 2022			96,289,668
Beginning balance at Mar. 31, 2022	721,125		$ 73	921,753	(897)	(200,180)		376
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,812
Common stock issued for exercise of employee-based stock options (in shares)			76,399
Common stock issued for exercise of employee-based stock options	734			734
Issuance of restricted shares, net of forfeitures and vesting (in shares)			42,388
Stock-based compensation	6,023			6,023
Net income (loss)	11,571					11,571
Foreign currency translation adjustment, net of tax				(24)				(3,483)
Foreign currency translation adjustment, net of tax	(3,507)
Ending Balance (in shares) at Jun. 30, 2022			96,410,267
Ending Balance at Jun. 30, 2022	735,946		$ 73	928,486	(897)	(188,609)		(3,107)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,604
Common stock issued for exercise of employee-based stock options (in shares)			159,350
Common stock issued for exercise of employee-based stock options	1,479		$ 2	1,477
Issuance of restricted shares, net (in shares)			(23,155)
Stock-based compensation	6,293			6,293
Net income (loss)	9,303					9,303
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(4,790)			(17)				(4,790)
Foreign currency translation adjustment, net of tax	(4,807)
Ending Balance (in shares) at Sep. 30, 2022			96,548,066
Ending Balance at Sep. 30, 2022	$ 748,214		$ 75	$ 936,239	$ (897)	$ (179,306)		$ (7,897)